Early stage IT and Healthcare Investing

Healthcare

Healthcare

Cidara

Tue, 07/01/2014 - 16:19 -- aestell

Cidara Therapeutics (Nasdaq: CDTX) is applying its small molecule immunotherapy platform to treat life-threatening illnesses exacerbated by deficiencies of the human immune system. Cidara's initial focus is on devastating fungal infections that often complicate cancer and transplant treatments.

Pages

Subscribe to RSS - Healthcare
Facebook Google+ Twitter Email LinkedIn Share